1 – 5 of 10
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis
(
- Contribution to journal › Article
-
Mark
Impact on follow-up strategies in patients with primary sclerosing cholangitis
(
- Contribution to journal › Article
- 2022
-
Mark
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
(
- Contribution to journal › Article
- 2021
-
Mark
The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients
(
- Contribution to journal › Article
-
Mark
Assessment of lifestyle factors helps to identify liver fibrosis due to non-alcoholic fatty liver disease in obesity
(
- Contribution to journal › Article